These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 30660942)

  • 1. Fetal fibronectin test for threatened preterm delivery 48h after admission: Cost-effectiveness study.
    Mourgues C; Rossi A; Favre N; Delabaere A; Roszyk L; Sapin V; Debost-Legrand A; Gallot D
    Eur J Obstet Gynecol Reprod Biol; 2019 Mar; 234():75-78. PubMed ID: 30660942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid fetal fibronectin testing to predict preterm birth in women with symptoms of premature labour: a systematic review and cost analysis.
    Deshpande SN; van Asselt AD; Tomini F; Armstrong N; Allen A; Noake C; Khan K; Severens JL; Kleijnen J; Westwood ME
    Health Technol Assess; 2013 Sep; 17(40):1-138. PubMed ID: 24060096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive performance of PAMG-1 vs fFN test for risk of spontaneous preterm birth in symptomatic women attending an emergency obstetric unit: retrospective cohort study.
    Melchor JC; Navas H; Marcos M; Iza A; De Diego M; Rando D; Melchor I; Burgos J
    Ultrasound Obstet Gynecol; 2018 May; 51(5):644-649. PubMed ID: 28850753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk stratification with cervical length and fetal fibronectin in women with threatened preterm labor before 34 weeks and not delivering within 7 days.
    Hermans FJR; Bruijn MMC; Vis JY; Wilms FF; Oudijk MA; Porath MM; Scheepers HCJ; Bloemenkamp KWM; Bax CJ; Cornette JMJ; Nij Bijvanck BWA; Franssen MTM; Vandenbussche FPHA; Kok M; Grobman WA; Van Der Post JAM; Bossuyt PMM; Opmeer BC; Mol BWJ; Schuit E; Van Baaren GJ
    Acta Obstet Gynecol Scand; 2015 Jul; 94(7):715-721. PubMed ID: 25845495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness analysis of cervical length measurement and fibronectin testing in women with threatened preterm labor.
    van Baaren GJ; Vis JY; Grobman WA; Bossuyt PM; Opmeer BC; Mol BW
    Am J Obstet Gynecol; 2013 Nov; 209(5):436.e1-8. PubMed ID: 23791688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The diagnostic value of fetal fibronectin testing in clinical practice.
    Cornelissen LGH; van Oostrum NHM; van der Woude DAA; Rolf C; Porath MM; Oei SG; van Laar JOEH
    J Obstet Gynaecol Res; 2020 Mar; 46(3):405-412. PubMed ID: 31955485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of diagnostic testing strategies including cervical-length measurement and fibronectin testing in women with symptoms of preterm labor.
    van Baaren GJ; Vis JY; Wilms FF; Oudijk MA; Kwee A; Porath MM; Scheepers HCJ; Spaanderman MEA; Bloemenkamp KWM; Haak MC; Bax CJ; Cornette JMJ; Duvekot JJ; Nij Bijvanck BWA; van Eyck J; Franssen MTM; Sollie KM; Vandenbussche FPHA; Woiski M; Bolte AC; van der Post JAM; Bossuyt PMM; Opmeer BC; Mol BWJ
    Ultrasound Obstet Gynecol; 2018 May; 51(5):596-603. PubMed ID: 28370518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of rapid bedside tests for phosphorylated insulin-like growth factor-binding protein 1 and fetal fibronectin to predict preterm birth.
    Tripathi R; Tyagi S; Mala YM; Singh N; Pandey NB; Yadav P
    Int J Gynaecol Obstet; 2016 Oct; 135(1):47-50. PubMed ID: 27388033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective, double-blinded cohort study using quantitative fetal fibronectin testing in symptomatic women for the prediction of spontaneous preterm delivery.
    Ng VWY; Seto MTY; Lewis H; Cheung KW
    BMC Pregnancy Childbirth; 2023 Apr; 23(1):225. PubMed ID: 37016314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical utility of fetal fibronectin in the prediction of pre-term birth in a low socio-economic setting hospital in Ecuador.
    Díaz J; Chedraui P; Hidalgo L; Medina M
    J Matern Fetal Neonatal Med; 2009 Feb; 22(2):89-93. PubMed ID: 19085632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Negative fetal fibronectin: who is still treating for threatened preterm labor and does it help?
    Peláez LM; Fox NS; Chasen ST
    J Perinat Med; 2008; 36(3):202-5. PubMed ID: 18576928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The predictive value of quantitative fibronectin testing in combination with cervical length measurement in symptomatic women.
    Bruijn MM; Kamphuis EI; Hoesli IM; Martinez de Tejada B; Loccufier AR; Kühnert M; Helmer H; Franz M; Porath MM; Oudijk MA; Jacquemyn Y; Schulzke SM; Vetter G; Hoste G; Vis JY; Kok M; Mol BW; van Baaren GJ
    Am J Obstet Gynecol; 2016 Dec; 215(6):793.e1-793.e8. PubMed ID: 27542720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the Actim Partus test and the fetal fibronectin test in the prediction of spontaneous preterm birth in symptomatic women undergoing cervical length measurement.
    Bruijn MM; Vis JY; Wilms FF; Oudijk MA; Kwee A; Porath MM; Oei G; Scheepers HC; Spaanderman ME; Bloemenkamp KW; Haak MC; Bolte AC; Vandenbussche FP; Woiski MD; Bax CJ; Cornette JM; Duvekot JJ; Nij Bijvank BW; van Eyck J; Franssen MT; Sollie KM; van der Post JA; Bossuyt PM; Opmeer BC; Kok M; Mol BW; van Baaren GJ
    Eur J Obstet Gynecol Reprod Biol; 2016 Nov; 206():220-224. PubMed ID: 27750180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of cervical length and quantitative fetal fibronectin for predicting spontaneous preterm delivery among symptomatic nulliparous women.
    Kyozuka H; Murata T; Sato T; Suzuki S; Yamaguchi A; Fujimori K
    Int J Gynaecol Obstet; 2019 Jun; 145(3):331-336. PubMed ID: 30941761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gestational age at cervical length and fetal fibronectin assessment and the incidence of spontaneous preterm birth in twins.
    Fox NS; Saltzman DH; Fishman A; Klauser CK; Gupta S; Rebarber A
    J Ultrasound Med; 2015 Jun; 34(6):977-84. PubMed ID: 26014316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of a novel test for placental alpha microglobulin-1 with fetal fibronectin and cervical length measurement for the prediction of imminent spontaneous preterm delivery in patients with threatened preterm labor.
    Nikolova T; Bayev O; Nikolova N; Di Renzo GC
    J Perinat Med; 2015 Jul; 43(4):395-402. PubMed ID: 25562603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of cervical gland area in predicting preterm birth for patients with threatened preterm delivery: comparison with cervical length and fetal fibronectin.
    Asakura H; Fukami T; Kurashina R; Tateyama N; Doi D; Takeshita T
    Gynecol Obstet Invest; 2009; 68(1):1-8. PubMed ID: 19321961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fetal fibronectin versus cervical length as predictors of preterm birth in twin pregnancy with or without 17-hydroxyprogesterone caproate.
    Combs CA; Garite TJ; Maurel K; Das A;
    Am J Perinatol; 2014 Dec; 31(12):1023-30. PubMed ID: 24566755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance of cervicovaginal fetal fibronectin in a community hospital setting.
    Incerti M; Ghidini A; Korker V; Pezzullo JC
    Arch Gynecol Obstet; 2007 May; 275(5):347-51. PubMed ID: 17051404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of fetal fibronectin testing for women with symptoms of preterm labour in routine clinical practice within a New Zealand population.
    Groom KM; Liu E; Allenby K
    Aust N Z J Obstet Gynaecol; 2006 Oct; 46(5):440-5. PubMed ID: 16953860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.